Geron reported $527.11M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Amgen USD 96.05B 409M Sep/2026
Bio Techne USD 2.64B 50.09M Sep/2026
Cassava Sciences USD 100.06M 3.84M Sep/2026
Cytokinetics USD 1.82B 99.77M Sep/2026
Exelixis USD 2.51B 19.26M Sep/2026
Genmab DKK 12.52B 139M Jun/2026
Geron USD 527.11M 8.1M Sep/2026
Gilead Sciences USD 51.41B 2.05B Sep/2026
Incyte USD 7.29B 585.39M Sep/2026
MacroGenics USD 318.68M 26.72M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Novavax USD 888M 67.57M Sep/2026